Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video navigators boost cancer screening in deaf community

NCT ID NCT06492993

Knowledge-focused Sponsor: Gallaudet University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether community health navigators who use American Sign Language (ASL) via videoconferencing could help deaf, deafblind, and hard-of-hearing adults complete recommended cancer screenings. The 184 participants were aged 45-80 and had early hearing loss. The navigators provided education and support over several sessions to guide them through the screening process.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Community health navigator support via videoconferencing
What this could lead to
If successful, this approach could improve cancer screening rates among deaf and hard-of-hearing adults who use ASL, potentially catching cancers earlier.
What could go wrong
This is a completed study with 184 participants, but results may not apply to all deaf communities or all cancer types. The intervention relies on participant willingness and access to videoconferencing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

184 people

The number who actually took part.

Started

Sep 2023

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and lifestyle considerations (see Section 5.3, Lifestyle Considerations) and availability for the duration of the study Male or female at birth age 45-80yo or female at birth age 45-80yo; age-eligible according to screening criteria Self-reported diagnosis of bilateral hearing loss at birth or prior to 13 years old (defined as "early deafness") and use ASL Willingness to adhere to the CHN clinical trial regimen Willingness to provide cancer screening verification documentation; this will be reviewed during the informed consent procedure Access to necessary resources to support video-based communication Non-adherent to one or more cancer screening guidelines for breast, lung, prostate, colon, cervical cancers will be those who reported not having had the appropriate recommended screenings within the past year to cancer screening questions in the HINTS-ASL survey Exclusion Criteria: * Presence of full ability to hear in one or both ears beyond 13 years of age Younger or older than the age cutoff for the recommended cancer screening Not capable of independently conducting the activities of daily living In compliance with age- or risk-specific screening at the time of evaluation for study eligibility Are currently undergoing cancer treatment or being evaluated for the presence of cancer at the time of evaluation for study eligibility Will be engaged in more than 21 consecutive days of travel during the eleven-month study window Knows other participants at baseline

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Deafness hearing loss disorder neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Deafness

Contacts and locations

Locations

  • Gallaudet University

    Washington D.C., District of Columbia, 20002, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.